Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) on July 5 and set a price target of $65.00. The company’s shares closed last Friday at $56.62.

According to TipRanks, Anderson CFA is an analyst with an average return of -9.1% and a 37.34% success rate. Anderson CFA covers the Healthcare sector, focusing on stocks such as R1 RCM, Walgreens Boots Alliance, and Augmedix.

Currently, the analyst consensus on CVS Health is a Moderate Buy with an average price target of $67.11.

CVS market cap is currently $71.08B and has a P/E ratio of 9.95.

Based on the recent corporate insider activity of 52 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CVS in relation to earlier this year.

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

CVS Health (CVS) Company Description:

Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.